You are here: Industry Insights > CDMO

News List

Maravai LifeSciences Expands CDMO Capabilities at TriLink contractpharma
August 26, 2020
To increase small molecule manufacturing capacity for additional scale-up of CleanCap messenger RNA capping technology for vaccine and therapeutic programs.
CDMO Sai Life Sciences Opens New Facility contractpharma
August 19, 2020
State-of-the-art research and technology center is located in Hyderabad, India and completes first phase in $150 million investment.
Swiss American CDMO Appears In 2020 Inc. 5000 List contractpharma
August 19, 2020
Swiss American CDMO, a Dallas-based company that specializes in topical skin care, OTC drugs, medical devices and wound care products, was ranked No. 3290 on the 2020 Inc. 5000 list.
U.S. Govt. Selects Grand River Aseptic Manufacturing to Help Combat COVID-19 contractpharma
August 11, 2020
HHS and Dept. of Defense call upon the U.S.-based CDMO to expand domestic fill/finish capacity under Operation Warp Speed.
Sekisui Invests $18.93 Million in Biopharma CDMO Business contractpharma
August 03, 2020
Sekisui has invested £14.4 million ($18.93 million) in its biopharma CDMO business aimed at cGMP microbial capacity expansion at the existing site in Maidstone, Kent to be completed by the second half of 2022.
Forge Biologics Completes Series A Financing contractpharma
August 03, 2020
The company is advancing development candidates for the treatment of Krabbe disease.
Avid Bioservices, Argonaut Enter Manufacturing Services Pact contractpharma
July 29, 2020
To offer integrated process development, drug substance manufacturing and drug product parenteral manufacturing.
GenScript Expands CDMO Capabilities contractpharma
July 24, 2020
Launches CDMO segment "GenScript ProBio" at inaugural GenScript Cell and Gene Therapy Industry Development & Cooperation Forum in Shanghai.
Bora Adds Four Business Development Directors contractpharma
July 24, 2020
Bora Pharmaceuticals, a full-service contract development and manufacturing organization (CDMO) which specializes in immediate and modified release tablets and capsules, along with serialized packaging, has appointed four business development directors..
Polpharma Fully Integrates Bioceros contractpharma
July 16, 2020
In 2016, Polpharma Biologics acquired Dutch based Bioceros and their proprietary cell line development platform CHOBC, as well as their discovery, process development and analytical capabilities.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 29 30 Next page